We provide R&D services and look for partnerships with manufacturers of veterinary drugs, nutritional supplements and animal food to satisfy the demand for innovative drug delivery systems and a more comprehensive range of ingredients to improve animal health and nutrition.

NOVEL DRUG DELIVERY SYSTEMS FOR VETERINARY MEDICINE

Worldwide, the population of both pet and food-producing animals has been steadily growing. Manufacturers of veterinary drugs, nutritional supplements, and animal food and feed are constantly searching for improved palatability, bioavailability, and efficiency. The development of new and more efficient drug-delivery systems is becoming increasingly important to ensure animal health and well-being.

Our advanced microencapsulation technology offers microcapsules with a controlled release function. Our smart microcapsules enhance the therapeutic indices of drugs by protecting the encapsulated drugs from the environment and leakage, and increasing their stability and bioavailability.

Most importantly, our innovative drug delivery systems also make it possible for veterinarians to modify the pharmacokinetic parameters of the drugs and finely tune the drug release rate over periods of hours to months to improve drug efficacy, prolong action, and optimise dosage. Our targeted drug release function is a reliable means to maximise therapeutic efficacy by delivering drugs to the target site (specific tissues, organs or cells) to achieve a desired concentration level, reduce dosage and minimise toxic effects on healthy tissues. Our timed-release function provides the convenience of dosing animals once rather than with repeated administration.

WE OFFER A BETTER ALTERNATIVE TO LIPOSOMES FOR VETERINARY MEDICINE AND NUTRITION

Today, liposomes are among the most effective and widespread delivery systems of therapeutic substances in animals. However, the use of liposomes is limited by their poor chemical and physical stability, leakage and fusion of encapsulated active substances, poor control over drug release, low loading capacity and high manufacturing costs. Also, the choice of active substances is limited. Another popular encapsulation system is the emulsification of compounds into microdroplets. Similarly to liposomes, emulsion droplets are unstable and lack controlled release function, enabling only passive elution. The emulsification process also limits the choice of active substances.

Our smart microcapsules are a better alternative to liposomes. In contrast to liposomes, our microcapsules are highly stable. Our technology creates a physical barrier isolating and protecting active substances against degrading factors, such as heat, sunlight, moisture, oxidation, or incompatibility and interactions with other ingredients. Effectively sealing the content, our microcapsules are stable, invisible, tasteless and odourless. They are biocompatible and biodegradable, have high loading capacity, are versatile, applicable for the incorporation of any active substances, from small to large, both hydrophilic and hydrophobic and are suitable for large-scale, cost-effective production. Most importantly, our programmed-shell microcapsules have a controlled release mechanism.

SMART CONTROLLED-RELEASE MICROCAPSULES FOR ANIMAL HEALTH

The most important advantage of our advanced microencapsulation technology and what makes us unique is the controlled drug delivery function. Our technology provides a versatile tool for the controlled and targeted delivery of active substances for better outcomes. It allows modulation of the release profile (time and site) and pharmacokinetics parameters without changes in the pharmacological properties of the therapeutic agents. Possessing unique microencapsulation know-how, we can precisely programme the release time of active substances, the location and the duration of the release, achieving efficacy at an entirely different level. We deliver active compounds to the target site, where they are most effective. And all this at a low price. Production costs are mainly determined by the price of polymers and encapsulated active substances, representing a fraction of the final price.

Our technology offers therapeutically highly efficient, low-risk and cost-effective drug delivery systems. The safer and more effective pharmacotherapy leads to reduced toxicity associated with lower drug doses, increasing safety for the consumers of livestock products. Our technology also has great potential to restore the use of old drugs by modifying their biodistribution, improving bioavailability, and reducing toxicity.

Our smart microcapsules can be delivered through the intramuscular, subcutaneous, intravenous, ocular, or intranasal route. Our technology can be applied in veterinary medicine to improve the delivery of analgesic, antimicrobial, antifungal, anticancer, and antiviral drugs and substances in companion and productive animals. Besides veterinary medicine, it can be used for feed additives as well as in transfection technologies and in the cryopreservation of stallion or bull semen.

We seek partnerships with manufacturers of veterinary drugs, nutritional supplements and animal food to bring our innovations to the market. Let us know what challenges you are facing and what you would like to improve for animal health and well-being. We will find a solution for you and will help you design advanced, tailor-made and fully customisable microencapsulation solutions.